替格瑞洛

中文同義詞: 替卡格雷;替格瑞洛;提卡格雷;(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-二氟苯)環(huán)丙基]氨基}-5-(丙基硫氧嘧啶)-3H-[1,2,3]-***[4,5-D]嘧啶-3-基]-5-(2-羥乙基)環(huán)戊烷-1,2-二醇;替卡格雷(單晶);替卡格雷,替格瑞洛

英文名稱(chēng): TICAGRELOR

英文同義詞: TICAGRELOR;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;Azd 6140;Unii-glh0314rvc;(1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;AR-C 126532XX;Ticagrelor(AR-C 126532XX;Ticagrelor (AZD6140)

CAS號(hào): 274693-27-5

分子式: C23H28F2N6O4S

分子量: 522.574

相關(guān)類(lèi)別: Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium *pounds;醫(yī)藥原料;原料藥;心血管藥物;Ticagrelor;替卡格雷;AZD6140;醫(yī)藥中間體

用途: 抗血凝藥。用于減少急性冠脈綜合征（ACS）患者的心血管死亡和心臟病發(fā)作。